ResMed | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Ansell USD 58.65M 19.15M 2024-06
AtriCure USD -3820000 2.13M 2025-06
Baxter International USD 272M 214M 2025-06
Cochlear AUD 274.6M 54.5M 2024-12
Cooper Companies USD 175.7M 9.1M 2025-07
CSL USD 1.98B 778M 2024-12
Dexcom USD 212.6M 78.9M 2025-06
Edwards Lifesciences USD 430.9M 36.1M 2025-06
Fisher Paykel Healthcare NZD 145.75M 72.35M 2025-03
Globus Medical USD -125953000 222.96M 2025-06
Haemonetics USD 70.84M 20.14M 2025-06
Hologic USD 260.9M 267.9M 2025-06
Idexx Laboratories USD 373.05M 56.51M 2025-06
Insulet USD 121.1M 71.8M 2025-06
Integra LifeSciences USD -1309000 14.65M 2025-06
Intuitive Surgical USD 746.9M 168.8M 2025-06
Masimo USD 64.5M 13.5M 2025-06
Medtronic USD 1.52B 81M 2025-07
Philips EUR 488M 334M 2025-06
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 455.06M 28.79M 2025-06
Sigma Healthcare AUD 6.86M 6.05M 2024-07
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Steris USD 316.5M 105.61M 2025-06
Teleflex USD 177.48M 47.16M 2025-06
Thermo Fisher Scientific USD 1.92B 200M 2025-06


ResMed Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.